WFG Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $0 | Buy |
104
+18
| +21% | – | ﹤0.01% | 1748 |
|
|
2017
Q1 | $0 | Sell |
86
-18
| -17% | – | ﹤0.01% | 1762 |
|
|
2016
Q4 | $0 | Sell |
104
-550
| -84% | – | ﹤0.01% | 1847 |
|
|
2016
Q3 | $2K | Hold |
654
| – | – | ﹤0.01% | 1429 |
|
|
2016
Q2 | $2K | Hold |
654
| – | – | ﹤0.01% | 1414 |
|
|
2016
Q1 | $2K | Buy |
654
+40
| +7% | +$122 | ﹤0.01% | 1379 |
|
|
2015
Q4 | $2K | Buy |
614
+64
| +12% | +$208 | ﹤0.01% | 1413 |
|
|
2015
Q3 | $3K | Buy |
+550
| New | +$3K | ﹤0.01% | 1375 |
|
|
2015
Q2 | – | Sell |
-2,000
| Closed | -$14K | – | 1905 |
|
|
2015
Q1 | $14K | Sell |
2,000
-2,370
| -54% | -$16.6K | ﹤0.01% | 1112 |
|
|
2014
Q4 | $34K | Sell |
4,370
-7,367
| -63% | -$57.3K | 0.01% | 1040 |
|
|
2014
Q3 | $88K | Buy |
11,737
+71
| +0.6% | +$532 | 0.02% | 711 |
|
|
2014
Q2 | $113K | Buy |
11,666
+68
| +0.6% | +$659 | 0.02% | 618 |
|
|
2014
Q1 | $96K | Buy |
11,598
+660
| +6% | +$5.46K | 0.02% | 651 |
|
|
2013
Q4 | $92K | Sell |
10,938
-16,320
| -60% | -$137K | 0.01% | 778 |
|
|
2013
Q3 | $217K | Buy |
27,258
+12,782
| +88% | +$102K | 0.03% | 462 |
|
|
2013
Q2 | $112K | Buy |
+14,476
| New | +$112K | 0.02% | 626 |
|